Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T19:06:58.658Z.
Calculation as of: 2026-10-06T19:06:58.658Z.
Quote observation: 2026-10-06T19:03:38.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4b900084dfad819c514917b73a3910c9d2e92354b8183d11bfa5ab73513aed11
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
SeaStar Medical Holding Corporation
Market Cap
$9.10M
EV/EBITDA Ratio
N/A
| NAME | MARKET CAP | EV/EBITDA RATIO |
|---|---|---|
| SeaStar Medical Holding Corporation (ICU) | $9.10M | N/A |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $9.00M | N/A |
| Jasper Therapeutics, Inc. (JSPR)vs › | $8.94M | N/A |
| Ainos, Inc. (AIMD)vs › | $9.65M | N/A |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.66M | N/A |
| MetaVia Inc. (MTVA)vs › | $9.88M | N/A |
| Valion Bio, Inc. (VBIO)vs › | $9.82M | N/A |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.32M | N/A |
| DataMEDS AI, Inc. (MEDS)vs › | $8.22M | N/A |
| HeartSciences Inc. (HSCS)vs › | $8.25M | N/A |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
